卡巴拉汀联合醒脑开窍针刺治疗阿尔茨海默病的临床研究
王羡强 李扬扬【摘要】 目的:探討卡巴拉汀联合醒脑开窍针刺治疗阿尔茨海默病的临床效果。方法:采用随机数字表法将2018年2月-2020年3月本院收治的100例阿尔茨海默病患者分为对照组50例与观察组50例,对照组采用卡巴拉汀治疗,观察组在对照组基础上联合醒脑开窍针刺治疗。比较两组治疗效果,观察两组治疗前后阿尔茨海默病评价量表-认知量表(ADAS-cog)、日常生活活动能力量表(ADL)、简易智力状况检查量表(MMSE)评分,并分析两组治疗前后血清谷胱甘肽过氧化酶(GSH-Px)、超氧化物歧化酶(SOD)和丙二醛(MDA)等相关氧化应激指标水平,比较两组不良反应发生情况。结果:观察组治疗总有效率为88.00%,显著高于对照组的70.00%(P0.05)。结论:卡巴拉汀联合醒脑开窍针刺可提高阿尔茨海默病的治疗效果,改善患者认知功能和日常生活能力,提高机体抗氧化能力,且安全性较好。
【关键词】 阿尔茨海默病 卡巴拉汀 醒脑开窍针刺 氧化应激
[Abstract] Objective: To explore the clinical effect of Rivastigmine combined with Xingnao Kaiqiao acupuncture in the treatment of Alzheimers disease (AD). Method: A total of 100 patients with AD admitted to our hospital from February 2018 to March 2020 were divided into the control group (n=50) and the observation group (n=50) according to the table of random numbers. The control group was treated with Rivastigmine and the observation group was treated with Xingnao Kaiqiao acupuncture on the basis of the control group. The therapeutic effects of two groups were compared ......
您现在查看是摘要页,全文长 11891 字符。